Companion Diagnostic Devices Market 2018 Global Share, Trend, Segmentation and Forecast to 2023

Global Companion Diagnostic Devices Market

Description

WiseGuyReports.Com adds” Companion Diagnostic Devices Market : Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012 to 2016 and Forecast 2017 to 2023 “Research To Its Database.

Companion diagnostics are medical devices, often an in-vitro device and provides the information that essential for safe and effective use of the corresponding drug or biotechnology product. Companion diagnostics are often developed along with drugs to aid in selecting or excluding the patient groups for the treatment with particular drug on basis of their biological characters. Companion diagnostics are developed based on biomarkers technology to predict response or severe toxicity of the drugs or biotechnological compounds. Companion diagnostics are majorly used in oncology area. 

Some of the factors like improved efficacy and safety profiles of drugs, Accelerated drug regulatory approvals, reduced healthcare expenditure and drug development costs, increasing partnerships between market players, government organizations and other research firms over the use of co diagnostics, emergence of new pharmaceuticals and diagnostics are driving the growth of the global companion diagnostics market. However, due to the regulatory uncertainty, complex clinical trial procedures and intellectual property issues in certain areas are the few issues which are restraining the growth of the global companion diagnostics devices market. 

Get sample Report @  https://www.wiseguyreports.com/sample-request/2868231-companion-diagnostic-devices-market-global-market-estimation-dynamics-regional-share
 

Global companion diagnostic devices are segmented on the basis of application, technology, end user and geographical region. 

Based on the application, global companion diagnostic devices are segmented as: 
Breast Cancer 
Colorectal Cancer 
Lung Cancer 
Urology 
Melanoma 
Gastric Cancer 
Others 

Based on the technology, global companion diagnostic devices are segmented as: 
Immunohistochemistry 
Molecular Diagnostics 
In-situ Hybridization 
FISH 
CISH 
Real-Time PCR 
Gene Sequencing 

Based on the end-user, global companion diagnostic devices are segmented as: 
Hospitals 
Diagnostic Centres 
Others 

The global companion diagnostic devices market is highly fragmented due to the presence of several established large and small suppliers. The competition in the market will intensify during the forecast period as vendors adopt strategies like M&A to develop new technologies. Product approval and launch will also help to increase the volume of available diagnostic devices in the market. In addition, the vendors also work on differentiating their products based on quality, the accuracy of results, and other value added services as it will help them to gain a competitive edge over their peers. 

Geographically, companion diagnostic devices market is segmented into five regions: North America, Europe, Latin America, Asia-Pacific and Middle East & Africa. North America expected to be major market for companion diagnostics owing to growth innovative technologies in biomarkers, increase in R&D investment in the region. Asia-Pacific and Europe are expected to grow at a significant rate owing to large patent and consumer base, increasing government initiatives developing healthcare infrastructure, and growing disposable income. 

Some of the players in companion diagnostic devices market are F. Hoffmann-La Roche Ltd.(Switzerland), Qiagen Ltd. (Germany), ARUP Laboratories (U.S.), Abbott Laboratories (U.S.), Biogenex Laboratories, Inc. (U.S), Thermo Fisher Scientific (U.S), Ventana Medical Systems Inc. (U.S), Myriad Genetics Inc. (U.S), and Danaher (U.S) and others. 

In June 2015, Ventana Medical Systems, Inc. (RocheGroup) has received USFDA approval for its ventana alk cdx assay, companion diagnostic to aid in the identification of patients for, xalkori (crizotinib) (Pfizer’s FDA approved targeted therapy) 

In July 2014, AstraZeneca collaborated with Roche to develop a plasma-based companion diagnostic test to support azd9291, for non-small-cell lung cancer 

Enquiry About Report @ https://www.wiseguyreports.com/enquiry/2868231-companion-diagnostic-devices-market-global-market-estimation-dynamics-regional-share

Table of Contents -Major Key Points

1. 
   Executive Summary 
2. Global Companion Diagnostic Devices Market Introduction 
   2.1. Global Companion Diagnostic Devices Market – Taxonomy 
       2.2. Global Companion Diagnostic Devices Market –Definitions 
         2.2.1. Technology 
         2.2.2. Application 
3. Global Companion Diagnostic Devices Market Dynamics 
   3.1. Drivers 
       3.2. Restraints 
       3.3. Opportunities/Unmet Needs of the Market 
       3.4. Trends 
       3.5. Global Companion Diagnostic Devices Market Dynamic Factors - Impact Analysis 
4. Global Companion Diagnostic Devices Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 
   4.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn) 
       4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) 
       4.3. Market Opportunity Analysis 
5. Global Companion Diagnostic Devices Market, By Technology, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn) 
   5.1. Immunohistochemistry 
         5.1.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn) 
         5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
         5.1.3. Market Opportunity Analysis 
       5.2. Molecular Diagnostics 
         5.2.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn) 
         5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
         5.2.3. Market Opportunity Analysis 
       5.3. In-situ Hybridization 
         5.3.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn) 
         5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
         5.3.3. Market Opportunity Analysis 
       5.4. FISH 
         5.4.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn) 
         5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
         5.4.3. Market Opportunity Analysis 
       5.5. CISH 
         5.5.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn) 
         5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
         5.5.3. Market Opportunity Analysis 
       5.6. Real-Time PCR 
         5.6.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn) 
         5.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
         5.6.3. Market Opportunity Analysis 
       5.7. Gene Sequencing 
         5.7.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn) 
         5.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
         5.7.3. Market Opportunity Analysis 

………..CONTINUED